• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home
  2. science

Category

science

2 videos

eXoZymes signifiy a sustainable paradigm shift in chemical production leveraging AI-engineered enzymes
science
eXoZymes signifiy a sustainable paradigm shift in chemical production leveraging AI-engineered enzymes February 12, 2025 · 686 views
The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth
interview
The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth May 22, 2024 · 1,281 views
  • Previous
  • 1
  • 2

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use